BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3123582)

  • 1. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of immunopathologic studies of human leprosy lesions in situ.
    Scollard DM
    Hawaii Med J; 1988 Feb; 47(2):54-8. PubMed ID: 3284839
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
    Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological analysis of skin reaction to My1 derived from Mycobacterium leprae.
    Narayanan RB; Ramu G; Malaviya GN; Sinha S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):46-51. PubMed ID: 3519804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of leprosy: cellular anergy to Mycobacterium leprae.
    Rojas-Espinosa O; Estrada-Parra S
    Arch Invest Med (Mex); 1989; 20(4):335-41. PubMed ID: 2518718
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reverse or inverse reaction - a present-day point].
    Carayon A
    Hansenol Int; 1981 Jun; 6(1):10-8. PubMed ID: 6749678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between allergy and immunity in leprosy.
    Maier M
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):116-39. PubMed ID: 3104515
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity to leprosy. 1. The proliferative response of murine T lymphocytes to Mycobacterium leprae.
    Douglas-Jones AG; Watson JD
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):412-20. PubMed ID: 3900249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hypersensitivity skin reactions to lepromin and antigens prepared from four other mycobacteria.
    Govil DC; Bhutani LK
    Lepr India; 1978 Oct; 50(4):550-4. PubMed ID: 374872
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent development in immunology of leprosy: roles of immunoregulatory cytokines in the establishment of immuno-unresponsiveness to M. leprae in leprosy patients].
    Tomioka H
    Nihon Rai Gakkai Zasshi; 1995 Jul; 64(2):69-84. PubMed ID: 7592164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients].
    Fliess EL; Ortiz MC; Corn J
    Hansenol Int; 1983 Jun; 8(1):9-17. PubMed ID: 6432692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of antimycobacterial chemotherapy on delayed hypersensitivity skin-test reactions in leprosy patients.
    Cree IA; Smith WC; Rees RJ; Beck JS
    Lepr Rev; 1988 Jun; 59(2):145-51. PubMed ID: 3073285
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological spectra in chronic infectious diseases.
    Turk JL
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:208-12. PubMed ID: 4604571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.